HPV Status Linked to Survival in Oropharynx Cancer
For patients with oropharynx cancer, HPV positivity is associated with improved survival after disease progression.
Diagnosis & Disease Information
Head and Neck Cancer Knowledge Low Among US Adults
Two-thirds of surveyed adults reported being not very or not at all knowledgeable about head and neck cancer.
Reduced-dose Radiation Safe for Certain Patients with Low-risk HPV-positive Oropharyngeal Cancer
CHICAGO, IL—Reduced-dose intensity-modulated radiotherapy after complete clinical responses to induction chemotherapy for operable stage III/IVA, human papillomavirus (HPV)-positive head and neck cancer appears to be safe and might improve patients’ quality of life.
Gabapentin Has Benefits in Oropharyngeal Cancer
ANAHEIM, CALIFORNIA—Among oropharyngeal patients receiving radiotherapy, gabapentin improved pain management and reduced weight loss, which potentially prevents the need for placement of a gastrostomy tube.
Oncogenic Oral HPV Prevalent in HPV+ Oropharyngeal Cancer
Oral HPV, HPV16 DNA commonly detected in patients with oropharyngeal cancer, but not their partners.
Before HPV Vaccine, Most Oropharyngeal Cancers Were HPV+
Most oropharyngeal cancers in the United States diagnosed between 1995 and 2005 were positive for human papillomavirus, specifically HPV 16 or 18.
ID’ing Different First Symptoms in Patients With Two Types of OPSCC
Patients with HPV-positive OPSCC report different symptoms than those with HPV-negative OPSCC, which may have an effect on how early the disease is diagnosed.
Oropharyngeal Cancer Incidence Is Increasing
From 1973 to 2009, the incidence of oropharyngeal squamous cell carcinoma (OPSCC) increased in patients younger than 45 years.
Cancer Deaths Down in the US
Death rates from cancer continue to decline in the United States
Insufficient Evidence to Support Primary Care Oral Cancer Screening
There is currently insufficient evidence to weigh the benefits and harms of PCP screening of asymptomatic adults for oral cancer.
- Loading...
Loading...
Loading... 
Loading...